Skip to main content
Neuroimage: Reports logoLink to Neuroimage: Reports
. 2026 Aug 1;6(3):100388. doi: 10.1016/j.ynirp.2026.100388

Leveraging pretrained vision transformers for classifying alcohol use disorder using raw resting-state EEG

A Bingly a, CD Richard a, B Porjesz a, JL Meyers a, DB Chorlian a, C Kamarajan a, G Pandey a, Martin H Plawecki b, W Kuang a, AK Pandey a, S Kinreich a,
PMCID: PMC13453449  PMID: 42576984

Abstract

Alcohol Use Disorder (AUD) is a prevalent neuropsychiatric condition affecting about 28 million adults in the USA, with few objective biomarkers to assist in its clinical diagnosis. In this study, we investigated the potential of deep learning to classify individuals with AUD using raw resting-state electroencephalogram (EEG) data. EEG recordings were obtained from the Collaborative Study on the Genetics of Alcoholism (COGA). The initial cohort included a total of 5402 recordings from 2710 participants (aged 13–83, mean age 24; 1512 males and 1198 females). Minimal preprocessing was applied to preserve the raw EEG features. We utilized EEGViT, a hybrid deep learning architecture that combines convolutional patch embedding with a Vision Transformer (ViT) pretrained on ImageNet, thereby enabling end-to-end learning directly from raw EEG input. The analysis groups were matched and stratified by age and sex. The architecture was evaluated independently on Cannabis Use Disorder (CUD) and Opioid Use Disorder (OUD). Results for the AUD model showed a classification accuracy of approximately 57% in the overall dataset, 55% for males, and 59% for females. The CUD model showed an accuracy of about 64%, with 58% for females and 67% for males. The OUD model showed an accuracy of about 63%, with 61% for females and 65% for males. Temporal analysis indicated higher accuracy in later minutes than in earlier ones. While modest, these findings provide preliminary evidence that transformer-based models can be applied to psychiatric classification using raw EEG data and establish a foundation for future research on EEG-based approaches.

Highlights

  • Deep learning to classify Alcohol Use Disorder from raw resting-state EEG.

  • Age and sex stratified analysis.

  • Hybrid transformer model with pretrained vision transformer.

  • The architecture was evaluated independently on Cannabis and Opioid Use Disorder.

  • Recorded later, EEG segments yield higher model accuracy than earlier ones.

1. Introduction

Alcohol Use Disorder (AUD) is a common and debilitating mental health condition marked by excessive habitual drinking and loss of control over drinking. (American Psychiatric Association, 2013). According to the 2024 National Survey on Drug Use and Health, 27.9 million people ages 12 and older had AUD in the past year in the United States (SAMHSA, 2025). Moreover, estimates suggest that alcohol played a role in at least 7.1% of emergency department visits (White et al., 2022), and an analysis of death certificates showed that deaths involving alcohol among people ages 16 and older accounted for 99,017 (Centers for Disease Control and PreventionN.C.f.H.S, 2024). These alarming facts highlight the critical importance of identifying objective and accurate biomarkers predictive of AUD diagnosis and outcomes. Such insights could contribute to preventive strategies and treatments, potentially intervening before the addiction fully develops.

Over the past several decades, AUD neuroimaging research using magnetic resonance imaging (MRI) (Mackey et al., 2019) (Guggenmos et al., 2017), functional MRI (fMRI) (Ekhtiari et al., 2024), and electroencephalogram (EEG) (Mumtaz et al., 2018a) (Kumari et al., 2023) (Manivannan et al., 2024) recordings has focused on developing predictive models and identifying biomarkers associated with the disorder. Studies using structural MRI have found cortical thinning and volume reductions in frontal and temporal regions associated with AUD, which have been used as input features for machine learning (ML) algorithms such as support vector machines (SVM) and random forests to create significant AUD classifiers (Mackey et al., 2019) (Guggenmos et al., 2017). fMRI has been used to detect altered brain connectivity patterns, particularly in the default mode and reward networks (Ekhtiari et al., 2024). EEG-based approaches using features such as spectral power values or event-related potential (ERP) have produced significant models that predict people with AUD (Mumtaz et al., 2018a). Despite significant advances, the ability to reliably detect individuals with AUD or accurately predict vulnerability based on biomarkers remains limited, largely due to the absence of objective, scalable diagnostic tools and the heterogeneity of clinical presentations and brain development (Arbabshirani et al., 2017; Zahr and Pfefferbaum, 2017). Moreover, while existing studies show encouraging results, they are often constrained by small sample sizes (Varoquaux, 2018), inconsistent data processing pipelines, and a lack of external validation, all of which hinder generalizability across populations (Scheinost et al., 2019) (Pulini et al., 2019).

Our current work focuses on classifying AUD individuals using a substantial amount of EEG data from the Collaborative Study on the Genetics of Alcoholism (COGA) (Begleiter, 1995). COGA is a landmark, longitudinal, multi-site research project aimed at identifying genetic, neurobiological, and environmental factors that contribute to the development and persistence of AUD and related conditions (Porjesz et al., 2005). EEG offers a noninvasive, cost-effective method for capturing brain activity with high temporal resolution and has shown promise in identifying neurophysiological markers of AUD (Kinreich et al., 2021). Among the various neuroimaging paradigms, resting-state assessment is particularly attractive for clinical applications due to its portability, simplicity, minimal task demands, reproducibility, and consistency across imaging and electrophysiological modalities (Meghdadi et al., 2021).

Resting state EEG findings, including elevated theta power at rest, most notably in the frontal, central, and parietal regions, have been identified among AUD relapsers (Mumtaz et al., 2018b). Resting parietal-occipital alpha power is consistently found to be reduced in AUD, while increased frontal-central beta activity is found in both active and abstinent individuals (Rangaswamy et al., 2004). Resting-state EEG functional connectivity shows enhanced slow-wave coupling (delta, theta, alpha) and stronger beta-band correlations within the parietal region (Kinreich et al., 2021).

While traditional methods for classifying AUD and identifying AUD biomarkers have relied on handcrafted features input to models such as logistic regression and k-nearest neighbors, more recent efforts have used convolutional and recurrent neural networks to classify AUD directly from raw or minimally processed EEG (Kumari et al., 2023) (Manivannan et al., 2024). Overprocessing of the signal may obscure subtle, yet important, discriminative features and introduce bias, thereby reducing the model's ability to learn meaningful patterns (Casson, 2019). Preserving the raw signal enables the model to learn potentially informative features that may be distorted or lost through aggressive preprocessing. This is particularly important in the context of AUD, where the question of widely accepted EEG biomarkers is still open.

Therefore, advanced AI/ML approaches are being developed to improve classification and prediction performance, incorporating methods such as quantum machine learning (Amin et al., 2025) and Vision Transformers (Khan et al., 2022). In the current study, we implemented an advanced deep learning model trained on the COGA EEG resting-state dataset. Deep learning models, particularly convolutional and recurrent neural networks, have demonstrated strong capabilities in learning directly from raw physiological signals, including EEG, without the need for extensive feature extraction (Schirrmeister et al., 2017) (Roy et al., 2019; Roy et al., 2019). More recently, transformer-based architectures, originally developed for natural language processing (Lin et al., 2022), have shown substantial promise in modeling EEG data due to their ability to capture long-range dependencies and flexible attention mechanisms (Vafaei and Hosseini, 2025) (Siddhad et al., 2024). Unlike Convolutional Neural Network (CNNs) or Recurrent Neural Networks (RNNs), transformers do not rely on fixed kernel sizes or sequential processing, making them well-suited to handle the non-stationary and multiscale characteristics of EEG signals. Specifically, variants such as Vision Transformers (ViT) have been successfully adapted for time series and physiological data, and recent work has demonstrated their competitive performance in EEG-based classification tasks (Modesitt et al., 2024) (Siddhad et al., 2024), including cognitive workload assessment (Pulver et al., 2023), sleep staging (Phan et al., 2022), and seizure detection (Sun et al., 2022).

Moreover, recent studies have shown that leveraging pretrained transformer models, either on large image or EEG-specific datasets, can provide beneficial inductive biases that improve classification performance when fine-tuned on smaller datasets (Modesitt et al., 2024). A recent review further highlights transfer learning with pretrained transformers as a promising strategy in EEG analysis (Vafaei and Hosseini, 2025). To further assess the robustness of the transformer architecture, we evaluated its performance on other substance use disorders in the COGA dataset, including Cannabis Use Disorder (CUD) and Opioid Use Disorder (OUD).

This study aims to classify AUD individuals by leveraging a transformer-based deep learning architecture specifically adapted for raw EEG and by using a large, longitudinal dataset. We will also evaluate the models with CUD and OUD data. Moreover, we aimed to investigate whether raw EEG signals contain discriminative features that could inform future development of automated, EEG-based screening tools for AUD.

2. Method

2.1. Dataset

Our cohort includes individuals from the COGA database. Initiated in 1989, COGA is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and currently spans ten research centers across the United States (Begleiter, 1995). The COGA study recruited nearly 18,000 individuals from families with a high density of AUD. Participants underwent behavioral, clinical, and neurophysiological evaluation, assessed repeatedly across the lifespan, providing extensive longitudinal data, including EEG recordings (Porjesz et al., 2005). All participants provided informed consent, and data collection protocols have been approved by Institutional Review Boards (IRBs) at each participating site.

2.2. Participants

A total of 2710 individuals were included in the analysis, comprising 1512 males and 1198 females (Table S1). Participant ages ranged from 13 to 83 years, with a mean age of 24.16 ± 12.52 years. The data included multiple participants’ visits, ranging from 1 to 9, with a mean of 2 visits per participant. At each visit, participants were assessed using the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA), which is a diagnostic instrument for AUD and other substance use disorders, in addition to EEG, neuropsychological, and behavioral assessments. Each participant was diagnosed as either having AUD (case group) or not having AUD (unaffected group), based on criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (American Psychiatric Association, 2013). In total, the dataset included 5402 visits, of which 2701 were labeled as AUD and 2701 were labeled as non-AUD (Table 1).

Table 1.

The distribution of the participants for the train, validation, and test datasets.

#Participants (% of total) #trials (% of total trials) %AUD Approx. no. of samples
Total 2710 5402 50% NA
Train 2170(80.07%) 4862(90.00%) 50% 305k
Validation 270 (9.96%) 270 (5.00%) 50% 64k
Test 270 (9.96%) 270 (5.00%) 50% 64k

2.3. EEG acquisition

Resting-state EEG closed-eyes data were acquired using a 64-channel EEG electrode cap, following the International 10-20 system for electrode placement. Recordings were acquired at a sampling rate of 500 Hz. During the recording, participants were seated in a comfortable chair in a dimly lit, acoustically and radio-electrically shielded room. They were instructed to keep their eyes closed and remain relaxed to minimize motor artifacts.

2.4. Preprocessing pipeline

The EEG preprocessing pipeline is illustrated in Fig. 1, and each step is detailed in the following subsections. To preserve the integrity of the raw EEG signals, preprocessing was kept to a minimum and consisted only of bandpass filtering.

Fig. 1.

Fig. 1

The preprocessing pipeline for EEG data.

2.4.1. Bandpass filters

To enhance signal quality and denoise signal artifacts due to motor, drift, and electrical interference, the EEG recordings were bandpass filtered between 1Hz and 60Hz (Luck, 2014; Urigüen and Garcia-Zapirain, 2015). Filtering was performed using a zero-phase finite impulse response (FIR) filter, commonly recommended for EEG preprocessing due to its ability to eliminate phase distortion while preserving the temporal structure of the signal (Tanner et al., 2015; Widmann et al., 2015). Uniform filtering was applied across all channels to maintain data integrity and consistency for downstream analyses.

2.4.2. Random under-sampling

Given the inherent class imbalance in the dataset, where the number of unaffected participants significantly exceeds the number of cases, it was crucial to address this disparity before model training. Class imbalance can lead to biased model performance, typically favoring the majority class and resulting in poor generalization to the minority class (He and Garcia, 2009). To mitigate this, we applied random under-sampling to the majority class (unaffected), resulting in a more balanced distribution, a strategy proven effective in the physiological signal classification context (Abdulsadig and Rodriguez-Villegas, 2024).

2.4.3. Demographic matching, comorbidity, site and family effect

With the influence of age on both brain structure and function, along with evidence of sex-related differences in brain activity (Austin, 2011; McKay et al., 2014), we performed age and sex matching between the cases and the unaffected (Kinreich et al., 2021). Each AUD case was matched with an unaffected of the same sex and within a ±5-years age range, consistent with our prior work, to optimize the trade-off between demographic parity and sample retention (Kinreich et al., 2021) (see Table S1 for details on groups' age and sex and the statistical tests). Family effects were assessed using a linear mixed-effects model with diagnostic label as a fixed effect and family as a random effect. The mixed-effects model showed negligible family-level contribution to the outcome (family variance = 0.00094; ICC = 0.10). A chi-square test of independence showed no significant association between site and the outcome (case, control) (χ2 = 3.65, df = 5, p = 0.60). These results suggest that the distribution of cases and controls did not differ across sites. Chi-square tests of independence revealed significant associations between the outcome (case, control) and both CUD and OUD (CUD: χ2 = 340.56, df = 1, p < 0.001; OUD: χ2 = 88.69, df = 1, p < 0.001), suggesting that these comorbid conditions are unequally distributed across groups (Table S1).

2.4.4. Validation and testing (random data splitting of participants)

Data were partitioned at the participant level (with some participants contributing multiple EEG recordings), ensuring that no participant included in the training set appeared in either the validation or test sets, and that participants in the test set were also excluded from the validation set. The same preprocessing pipeline was applied to the validation and test sets, with additional constraints to ensure robust evaluation. The constraints include strictly age- and sex-matched. All recordings were trimmed to a standardized 4-min duration. Moreover, it was ensured that no more than 1 recording per participant was included. Restricting evaluation to one recording per participant further ensured that performance metrics reflected subject-level rather than recording-level generalization, avoiding pseudoreplication. Together, these measures minimized the risk of data leakage between training and evaluation, as well as confounding from demographic and sampling variability.

2.4.5. Epoching

Each EEG signal was divided into 1-s non-overlapping epochs, yielding multiple samples of 500 time points per channel (Modesitt et al., 2024), as illustrated in Fig. 2A. This window size was chosen to balance temporal resolution and computational feasibility. Each epoch was treated as an independent sample during training and evaluation.

Fig. 2.

Fig. 2

Epoching and the EEGViT model architecture. A. The 64-channel, 500Hz EEG recording was divided into 1-s non-overlapping epochs. These 1-s epochs serve as input to the model as images. B. The model consists of a patch embedding module that applies temporal and spatial convolutions to the raw EEG signal, followed by a Vision Transformer (ViT) encoder pretrained on ImageNet. The output is then passed through a classification head to predict AUD.

2.5. Model - EEGViT

We employed a hybrid deep learning model called EEGViT, adapted from the hybrid pretrained Vision Transformer approach for EEG of Modesitt et al. (2024) (Modesitt et al., 2024). It is based on the ViT architecture (Khan et al., 2022), with modifications to better capture the spatiotemporal structure of raw EEG signals. Specifically, the model incorporates a two-step convolutional embedding process prior to the transformer layers. The model operated on 1-s EEG segments, a matrix of 64x500 (channels x time). These short segments were used due to the computational and sequence length limitations of the ViT model, which make it infeasible to process entire 4-min recordings directly. Segmenting the EEG in this way also standardizes input size and enables batch-wise training.

The patch embedding module consisted of two convolutional layers designed to mimic temporal and spatial filtering typically used in EEG signal processing. The first layer applies a 1×T convolution across the temporal dimension for each channel. This temporal convolution can be interpreted as a learnable set of bandpass filters, allowing the model to extract frequency-specific features directly from the raw signal (Schirrmeister et al., 2017). The output feature maps capture relevant temporal dynamics associated with the EEG signal.

The second layer applies a depth-wise C×1 convolution across the spatial (channel) dimension, acting as a frequency-specific spatial filter. This enables the model to learn localized spatial features by aggregating information across EEG channels, similar to spatial filtering techniques such as common spatial patterns (CSP), but in a data-driven manner.

The output of the patch embedding module is a set of C×T feature maps, which are then reshaped into fixed-size patches and passed to a standard ViT encoder. Fig. 2B illustrates the model architecture.

The core of the model is a ViT encoder pretrained on ImageNet. Although ImageNet pretraining is originally intended for visual tasks, recent work has shown that pretrained ViT backbones provide useful inductive biases and generalizable priors that benefit EEG-based classification tasks, even in domains with significant differences from natural images (Srinivasan et al., 2022; Khan et al., 2022). The encoder employs multi-head self-attention mechanisms to model long-range dependencies across the temporal and spatial dimensions of the EEG data. The encoded representations are passed through a final classification head to predict AUD.

2.6. Training procedure

The EEGViT model was trained using a combination of optimization techniques, fine-tuning strategies, regularization methods, and data augmentation to enhance generalization and performance. The AdamW optimizer was used, decoupling weight decay from gradient updates, allowing for more stable training and improved regularization (Adablanu et al., 2026). The learning rate followed a cosine annealing schedule, enabling gradual decay and periodic resets to help escape local minima (Adablanu et al., 2026). The initial learning rate was set to 1e-4, and warm restarts were applied every 5 epochs.

2.6.1. Progressive fine-tuning schedule

During training, a progressive fine-tuning schedule was employed to gradually adapt different parts of the model. Initially, only the patch embedding layers were trained for the first two epochs to stabilize early learning. Next, the classifier and positional embeddings were unfrozen and trained with a moderately high learning rate of 1e-4 and weight decay of 1e-4, combined with a cosine annealing scheduler over 5 epochs. Subsequently, the top transformer encoder layers (layers 9, 10, and 11) and layer normalization parameters were unfrozen and fine-tuned with a reduced learning rate of 1e-5, also following a cosine annealing schedule. The remaining transformer encoder layers were progressively unfrozen in stages across subsequent epochs until the entire transformer backbone was trained. This gradual unfreezing approach allowed for stable and effective transfer learning, mitigating sudden shocks to pretrained weights and improving convergence. The transition between each phase was based on early stopping, and the early stopping metric was reset in each phase to avoid premature convergence (Prechelt, 2012).

2.6.2. Data augmentation

Data augmentation strategies were implemented during training to improve the model's robustness to variability in the EEG signal. Gaussian noise with a mean and a standard deviation similar to the dataset was added to the input segments to simulate sensor or environmental noise (Shorten and Khoshgoftaar, 2019). In addition, the start point of the first 1-s input window was randomly shifted within a 0 to 1-s range, creating variability in the temporal alignment of the segments. These augmentations were applied on-the-fly during training and were not used for validation or testing, ensuring the integrity of model evaluation (Shorten and Khoshgoftaar, 2019).

2.7. Additional analysis

2.7.1. Time-stratification

To further investigate the temporal dynamics of model performance, we examined how classification accuracy varied across different segments of the EEG recording. Specifically, a subset of the data (participants with 5-min recordings) was used to assess the model's accuracy on all possible contiguous time windows within this time span. For example, given a 5-min EEG recording, the following combinations were assessed: 0-1min, 0-2min, 0-3min, 0-4min, 0-5min, 1-2min, 1-3min, 1-4min, 1-5min, 2-3min until all interval combinations had been assessed.

2.7.2. Model evaluation with CUD & OUD data

To evaluate whether the proposed EEGViT architecture can be used to model other substance-related conditions, we extended our analysis to additional use disorders available in the COGA dataset - CUD and OUD. For each disorder, participants were categorized as cases or unaffected, where cases met diagnostic criteria for the respective disorder based on DSM-5, similar to AUD. The number of participants in each of the analyses (CUD, OUD) is provided in Table S2 and S3.

The same preprocessing pipeline was applied to the EEG data, including bandpass filtering, demographic matching, and random undersampling to achieve balanced class representation. Each model was trained independently for each disorder using the EEGViT architecture, with identical training procedures and hyperparameter configurations. Training was conducted from scratch for each disorder to ensure that model weights were not influenced by prior AUD-specific learning.

Performance metrics (accuracy, precision, recall, F1-score, and ROC-AUC) were computed for each disorder using an independent test set. This analysis provided insight into whether the proposed transformer-based framework could capture shared or disorder-specific EEG signatures and whether pretrained ViT representations could be used across different substance use disorders by identifying common or distinct neurophysiological patterns for classification.

2.7.3. Age-stratification

EEG characteristics are known to vary substantially with age due to developmental and aging-related changes in brain structure and function. To evaluate whether age-related variability influenced model performance, we conducted a post hoc age-stratified analysis using the same trained EEGViT model. Specifically, we selected a subsample of participants aged 20–40 years, representing a relatively homogeneous adult cohort in which both brain maturation and age-related decline effects are minimal. This range was chosen to reduce potential confounding from developmental (adolescent) or aging (older adult) neural differences that may alter EEG spectral power or connectivity patterns independent of AUD status.

The previously trained EEGViT model was applied directly to this age-restricted test set without further fine-tuning or retraining. The same preprocessing and matching procedures were maintained to ensure consistency. Performance metrics were computed to assess whether the model's classification ability improved within this narrower age window, providing insight into the influence of age heterogeneity on EEG-based AUD detection.

2.7.4. Effectiveness of using a pre-trained model

To assess the effectiveness of pretraining, we trained the same architecture on the AUD dataset using identical training and evaluation procedures, but with randomly initialized weights instead of pretrained weights. The performance of the pretrained and non-pretrained models was then compared descriptively using the model metrics, and the predicted values were compared statistically using a paired t-test.

3. Results

3.1. AUD model

The EEGViT model was used to classify individuals with AUD versus those who are unaffected. The results presented in Table 2 indicate a moderate classification performance for the analysis that included the entire test dataset, with an accuracy of 57.01%, a precision of 55.80%, a recall of 86.51%, and an F1-score of 67.84%. The evaluation was also repeated after sex stratification, the model performed with an accuracy of 59.32%, a precision of 57.97%, a recall of 86.94%, and an F1-score of 69.56% (females); and with an accuracy of 54.65%, a precision of 53.61%, a recall of 86.04%, and an F1-score of 66.06% (males).

Table 2.

Classification results for the AUD Model.

Age Group Sex Group Accuracy (95% confidience interval) Precision (95% confidience interval) Recall (95% confidience interval) F1 Score (95% confidience interval) ROC-AUC (95% confidience interval)
All All 0.5701 (±0.0050) 0.5580 (±0.0059) 0.8651 (±0.0062) 0.6784 (±0.0051) 0.5552 (±0.0057)
All Females 0.5932 (±0.0070) 0.5797 (±0.0085) 0.8694 (±0.0087) 0.6959 (±0.0072) 0.5727 (±0.0081)
All Males 0.5465 (±0.0069) 0.5361 (±0.0082) 0.8604 (±0.0086) 0.6606 (±0.0073) 0.5381 (±0.0080)
20-40y All 0.5775 (±0.0061) 0.5869 (±0.0072) 0.8438 (±0.0073) 0.6923 (±0.0061) 0.5389 (±0.0072)
20-40y Females 0.5744 (±0.0081) 0.5599 (±0.0101) 0.8485 (±0.0104) 0.6737 (±0.0061) 0.5629 (±0.0094)
20-40y Males 0.5813 (±0.0089) 0.6190 (±0.0104) 0.8386 (±0.0105) 0.7122 (±0.0085) 0.5020 (±0.0099)

Fig. 3 illustrates the model accuracy for different time segments within the 5-min resting-state EEG recording. Model performance was lowest during the first minute (0–1 min; accuracy = 0.56, 95% CI: 0.552–0.568) and increased in later portions of the recording, reaching its highest performance between 3 and 5 min (accuracy = 0.62, 95% CI: 0.612–0.628), with non-overlapping 95% confidence intervals.

Fig. 3.

Fig. 3

Time-stratification analysis. The figure shows the accuracy of AUD prediction across varying time windows.

3.2. Model evaluation with CUD & OUD data

For the CUD model (Table 3), overall classification performance was moderate, achieving an accuracy of 64%, precision of 62%, recall of 88%, and an F1-score of 73% across all participants. When stratified by sex, the model performed better among males (accuracy = 67%, F1 = 79%) compared with females (accuracy = 58%, F1 = 67%).

Table 3.

Classification results for the CUD Model.

Age Group Sex Group Accuracy (95% confidence interval) Precision (95% confidence interval) Recall (95% confidence interval) F1 Score (95% confidence interval) ROC-AUC (95% confidence interval)
All All 0.64 (±0.01) 0.62 (±0.01) 0.88 (±0.01) 0.73 (±0.01) 0.61 (±0.01)
All Females 0.58 (±0.02) 0.54 (±0.02) 0.87 (±0.02) 0.67 (±0.02) 0.59 (±0.02)
All Males 0.67 (±0.02) 0.73 (±0.02) 0.88 (±0.02) 0.79 (±0.02) 0.60 (±0.02)

For the OUD model (Table 4), the overall performance was similar, with an accuracy of 63%, a precision of 60%, a recall of 76%, and an F1-score of 67%. In sex-specific analyses, females exhibited slightly higher recall (81%) but lower precision (58%), yielding an F1-score of 68%, while males showed more balanced precision (63%) and recall (71%) with an F1-score of 67%.

Table 4.

Classification results for the OUD Model.

Age Group Sex Group Accuracy (95% confidence interval) Precision (95% confidence interval) Recall (95% confidence interval) F1 Score (95% confidence interval) ROC-AUC (95% confidence interval)
All All 0.63 (±0.03) 0.60 (±0.03) 0.76 (±0.01) 0.67 (±0.02) 0.63 (±0.03)
All Females 0.61 (±0.02) 0.59 (±0.01) 0.81 (±0.02) 0.68 (±0.01) 0.61 (±0.02)
All Males 0.65 (±0.03) 0.62 (±0.03) 0.71 (±0.01) 0.77 (±0.02) 0.65 (±0.03)

Both models exhibited consistent performance across evaluation metrics, indicating that the EEGViT framework can be applied to additional substance use disorder classifications using EEG data. Comorbidity between the substances is shown in Table S4 and S5, suggesting that the conditions are unequally distributed across groups.

3.3. Effectiveness of using a pre-trained model

Across repeated evolutions, the pretrained model consistently outperformed the model initialized with random weights. The model achieved an accuracy of 0.549 ± 0.035, precision of 0.546 ± 0.039, recall of 0.590 ± 0.039, F1 score of 0.566 ± 0.033, and ROC-AUC of 0.549 ± 0.039. A paired t-test between the logits of the two models showed that the difference was statistically significant (p < 0.05).

4. Discussion

In this study, we explored the feasibility of using a pretrained transformer-based deep learning architecture to classify individuals with AUD from raw resting-state EEG data. Leveraging a large, longitudinal dataset from COGA, our model was trained end-to-end on 1-s raw EEG segments using minimal preprocessing. Our AUD model achieved a modest overall accuracy on the whole sample and showed similar results when stratified by sex and age. Additionally, the model performance at different time intervals showed higher accuracy in the later minutes compared to the earlier ones. The CUD and OUD models achieved similar results, while the accuracy on the male subset was observed to be slightly higher than that of the female subset. This study provides meaningful insights into the current capabilities and challenges of EEG-based AUD detection using transformer models.

Our results demonstrate classification performance for AUD achieved using a pretrained vision transformer model (Ranasinghe and Mapa, 2024). The classification results within the narrower age range of 20-40 years were largely consistent with those from the full dataset, suggesting that age heterogeneity did not substantially bias model performance when based on raw data. Nonetheless, the restricted age analysis indicated slightly higher F1-scores in males, aligning with the broader sex-specific trend observed across this study's models. These findings suggest that while EEGViT model remains robust across adult age ranges, future studies with larger and more evenly distributed age cohorts are needed to better characterize potential age-related differences in EEG-based substance use disorder classification.

Advances in AI and machine learning are creating new venues for classifying and diagnosing individuals with AUD using neuroimaging data. In the current work, we present a first attempt to utilize an EEG-pretrained Vision Transformer model to classify AUD. Using a pre-trained model reduces the reliance on large datasets, a resource often scarce in neuroimaging research (Han et al., 2021). Additionally, pretrained models act as a strong initialization, guiding optimization toward better generalizable solutions and often achieving higher accuracy with less training time and computational cost than models trained from scratch (Han et al., 2021). By capturing rich, transferable representations, such as linguistic patterns in text or visual features in images, pretrained models enable faster convergence, improved robustness to distribution shifts, and strong baseline performance across a variety of domains (Srinivasan et al., 2022).

The model was trained on raw EEG signals, without relying on handcrafted features. We hypothesized that advanced algorithms could identify patterns that conventional preprocessing might obscure or eliminate. However, the moderate model performance indicates that further refinement of the model or training process is needed to enable effective classification. Interestingly, the results show relatively higher recall, suggesting the model is more sensitive in identifying AUD cases than it is specific in rejecting non-AUD cases.

Similar results were observed when the analysis was stratified by sex. The deep learning models were unable to distinguish sex-related variability in EEG signals from differences in the manifestation of AUD-related neurophysiological markers. Prior literature suggested sex-related heterogeneity in both brain structure and the clinical presentation of AUD (Hill et al., 2023). For example, EEG beta power is generally higher in young males with AUD, and they usually exhibit greater interhemispheric connectivity, whereas young females with AUD tend towards enhanced interhemispheric connectivity (Elliott et al., 2025); P3 appears to be particularly sensitive to alcohol misuse, with males exhibiting a lower amplitude than young females (Elliott et al., 2025). Future analyses will require further model development to improve sensitivity to sex-specific differences.

Beyond AUD, we also evaluated whether the EEGViT architecture could be used with other substance use disorders. The models trained for CUD and OUD achieved similar overall accuracies. These results suggest that the model captures EEG features that extend beyond alcohol-specific effects, potentially reflecting shared neurophysiological alterations across substance use disorders (Bahji, 2024; Jegede et al., 2022). Indeed, a recent review of sixty scientific manuscripts concluded that substance use disorders share significant similarities in their genetic architectures and phenotypic profiles (Bahji, 2024).

Interestingly, results show that the model was more accurate in classification when given raw EEG resting-state signals from the later part of the recordings. That is, the model performed better without the first few minutes of the EEG resting-state. This temporal trend may reflect initial, settling, or adaptation effects, where early EEG signals capture residual cognitive or physiological noise (e.g., physical movements, eye blinks, or transition into rest) (Getzmann et al., 2024; Liu et al., 2024) that may obscure AUD-related features. Alternatively, later segments may contain additional information, allowing the model to extract more discriminative knowledge. These findings suggest that temporal selection may influence EEG-based AUD classification, and future work could explore weighting or segment selection strategies to optimize model input.

There are several factors that may contribute to the relatively low classification performance. First, EEG signals are inherently noisy and subject to substantial inter-individual variability (Liu et al., 2024), which may limit model generalizability. Although we implemented demographic matching and class balancing strategies, other unmeasured confounders, such as comorbid psychiatric conditions, medication use, or environmental influences, may still impact EEG patterns and confound classification (McKay et al., 2014). Second, while ViT-based models offer theoretical advantages in modeling long-range dependencies, they may require larger datasets or domain-specific pretraining to achieve their full potential. The pretraining used in this study (on ImageNet) may not transfer optimally to EEG data, which differs substantially from natural images in structure and information content.

Moreover, the use of short (1-s) EEG epochs, although computationally efficient, may limit the amount of contextual information available to the model. Incorporating longer temporal segments or leveraging hierarchical models that integrate across multiple time scales could improve classification performance. Additionally, the model may benefit from multimodal integration, such as incorporating clinical or genetic information from the COGA dataset alongside EEG, to capture a more holistic representation of AUD risk (Kinreich et al., 2019).

Vision Transformers have gained increasing attention for neuroimaging classification tasks in recent years, demonstrating promising performance in applications such as brain cancer (Sarwar et al., 2026) and an Alzheimer's disease diagnosis (Ali et al., 2024). Our work adds to the current interest in AI, specifically in pretrained transformers classifying neuroimaging data. Specifically, this work demonstrated the potential of transformer-based architectures to learn discriminative features directly from raw EEG for AUD classification. While the current performance may not yet support clinical deployment, this work lays the groundwork for future studies that aim to refine model architecture, integrate auxiliary data, and explore domain-specific pretraining approaches.

5. Limitations and future directions

While the current study demonstrates the feasibility of transformer-based EEG modeling for substance use disorder classification, several limitations warrant consideration.

Although the COGA dataset is among the largest publicly available EEG resources on AUD, deep learning models would benefit from a more diverse and larger dataset. It would enable more generalizability and also enable the use of more complex model architectures that can leverage both temporal and spatial dependencies within and across EEG channels. Our results suggest the presence of substance use comorbidity within the dataset. Future studies using larger and more carefully characterized cohorts may help disentangle substance-specific effects. Additionally, the use of short, 1-s epochs may restrict the temporal context available to the model. Longer window sizes or models capable of integrating multiscale temporal dynamics could enhance discrimination of use-related neural patterns. Epoching is a common practice in EEG-based deep learning, as it increases the amount of training data while preserving subject-level independence during model evaluation. However, because multiple epochs originate from the same recording, the resulting samples are not fully independent. Therefore, validation on larger, independent datasets is necessary to confirm the robustness and generalizability of the proposed approach. In addition, the ViT architecture used here was pretrained on natural images, which differ markedly from EEG signals. Additionally, explainable AI techniques such as attention-based saliency mapping should be applied to identify which EEG features or brain regions most strongly drive classification. This could not only improve interpretability but also facilitate the discovery of novel electrophysiological biomarkers of substance use risk. The results presented in this study are modest. We anticipate that implementing the recommendations outlined above in future studies will improve both classification performance and the generalizability of the proposed approach.

Declaration of generative AI and AI-assisted technologies in the manuscript preparation process

The authors affirm that no generative AI systems were used to create, analyze, or interpret data in this manuscript. Generative AI tools (e.g., ChatGPT) were used only to assist with minor language editing. All scientific content, analyses, and conclusions are the sole work of the authors.

CRediT authorship contribution statement

A. Bingly: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft. C.D. Richard: Investigation, Methodology. B. Porjesz: Conceptualization, Funding acquisition, Writing – review & editing. J.L. Meyers: Resources, Writing – review & editing. D.B. Chorlian: Conceptualization, Methodology, Writing – review & editing. C. Kamarajan: Data curation, Investigation, Writing – review & editing. G. Pandey: Investigation, Writing – review & editing. Martin H. Plawecki: Writing – review & editing. W. Kuang: Data curation, Formal analysis, Writing – review & editing. A.K. Pandey: Conceptualization, Data curation, Investigation, Writing – review & editing. S. Kinreich: Investigation, Methodology, Supervision, Validation, Writing – original draft.

Declaration of competing interest

The authors declare no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

Support for this research came from the National Institute on Alcohol Abuse and Alcoholism (AA029448) and the Collaborative Study on the Genetics of Alcoholism project grant (U10AA008401).

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.ynirp.2026.100388.

Appendix A. Supplementary data

The following is the Supplementary data to this article:

Multimedia component 1
mmc1.docx (29.9KB, docx)

Data availability

Data will be made available on request.

References

  1. Abdulsadig R.S., Rodriguez-Villegas E. A comparative study in class imbalance mitigation when working with physiological signals. Front. Digit. Health. 2024;6 doi: 10.3389/fdgth.2024.1377165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adablanu S., Barman U., Das D. 15 years of optimizers in medical deep learning: a systematic review. Neurosci. Informatics. 2026;6 doi: 10.1016/j.neuri.2025.100249. [DOI] [Google Scholar]
  3. Ali M.U., Kim K.S., Khalid M., Farrash M., Zafar A., Lee S.W. Enhancing Alzheimer's disease diagnosis and staging: a multistage CNN framework using MRI. Front. Psychiatr. 2024;15 doi: 10.3389/fpsyt.2024.1395563. 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. American Psychiatric Association . 5 ed. American Psychiatric Association; Washington, DC: 2013. Diagnostic and Statistical Manual of Mental Disorders : DSM-5. [DOI] [Google Scholar]
  5. Amin J., Ali M.U., Islam M.Z., Lee S.W. Quantum AI for psychiatric diagnosis: enhancing dementia classification with quantum machine learning. Front. Psychiatr. 2025;16 doi: 10.3389/fpsyt.2025.1648060. 2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arbabshirani M.R., Plis S., Sui J., Calhoun V.D. Single subject prediction of brain disorders in neuroimaging: promises and pitfalls. Neuroimage. 2017;145:137–165. doi: 10.1016/j.neuroimage.2016.02.079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Austin P.C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav. Res. 2011;46:399–424. doi: 10.1080/00273171.2011.568786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bahji A. Navigating the complex intersection of substance use and psychiatric disorders: a comprehensive review. J. Clin. Med. 2024;13 doi: 10.3390/jcm13040999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Begleiter H. The collaborative study on the genetics of alcoholism. Alcohol Health Res. World. 1995;19:228–236. https://pmc.ncbi.nlm.nih.gov/articles/PMC6875768/ [PMC free article] [PubMed] [Google Scholar]
  10. Casson A.J. Wearable EEG and beyond. Biomed. Eng. Lett. 2019;9:53–71. doi: 10.1007/s13534-018-00093-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Centers for Disease Control and Prevention, N.C.f.H.S . Centers for Disease Control and Prevention; 2024. National Vital Statistics System, Provisional Mortality on CDC WONDER Online Database.http://wonder.cdc.gov/mcd-icd10-provisional.html [Google Scholar]
  12. Ekhtiari H., Sangchooli A., Carmichael O., Moeller F.G., O'Donnell P., Oquendo M.A., Paulus M.P., Pizzagalli D.A., Ramey T., Schacht J.P., Zare-Bidoky M., Childress A.R., Brady K. Neuroimaging biomarkers of addiction. Nat. Mental Health. 2024;2:1498–1517. doi: 10.1038/s44220-024-00334-x. [DOI] [Google Scholar]
  13. Elliott A.S., Moreno-Fernández R.D., Sampedro-Piquero P. Effects of alcohol on EEG activity: a systematic review focused on sex-related differences in youth. Curr. Neuropharmacol. 2025;23:705–727. doi: 10.2174/1570159x23666241106095027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Getzmann S., Gajewski P.D., Schneider D., Wascher E. Resting-state EEG data before and after cognitive activity across the adult lifespan and a 5-year follow-up. Sci. Data. 2024;11:988. doi: 10.1038/s41597-024-03797-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Guggenmos M., Schmack K., Sekutowicz M., Garbusow M., Sebold M., Sommer C., Smolka M.N., Wittchen H.U., Zimmermann U.S., Heinz A., Sterzer P. Quantitative neurobiological evidence for accelerated brain aging in alcohol dependence. Transl. Psychiatry. 2017;7:1279. doi: 10.1038/s41398-017-0037-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Han X., Zhang Z., Ding N., Gu Y., Liu X., Huo Y., Qiu J., Yao Y., Zhang A., Zhang L., Han W., Huang M., Jin Q., Lan Y., Liu Y., Liu Z., Lu Z., Qiu X., Song R., et al. Pre-trained models: past, present and future. AI Open. 2021;2:225–250. doi: 10.1016/j.aiopen.2021.08.002. [DOI] [Google Scholar]
  17. He H.B., Garcia E.A. Learning from imbalanced data. IEEE Trans. Knowl. Data Eng. 2009;21:1263–1284. doi: 10.1109/Tkde.2008.239. [DOI] [Google Scholar]
  18. Hill A.T., Bailey N.W., Zomorrodi R., Hadas I., Kirkovski M., Das S., Lum J.A.G., Enticott P.G. EEG microstates in early-to-middle childhood show associations with age, biological sex, and alpha power. Hum. Brain Mapp. 2023;44:6484–6498. doi: 10.1002/hbm.26525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jegede O., Rhee T.G., Stefanovics E.A., Zhou B., Rosenheck R.A. Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample. Psychiatry Res. 2022;315 doi: 10.1016/j.psychres.2022.114720. [DOI] [PubMed] [Google Scholar]
  20. Khan S., Naseer M., Hayat M., Zamir S.W., Khan F.S., Shah M. Transformers in vision: a survey. ACM Comput. Surv. 2022;54 doi: 10.1145/3505244. [DOI] [Google Scholar]
  21. Kinreich S., McCutcheon V.V., Aliev F., Meyers J.L., Kamarajan C., Pandey A.K., Chorlian D.B., Zhang J., Kuang W., Pandey G., Viteri S.S., Francis M.W., Chan G., Bourdon J.L., Dick D.M., Anokhin A.P., Bauer L., Hesselbrock V., Schuckit M.A., Nurnberger J.I., Jr., Foroud T.M., Salvatore J.E., Bucholz K.K., Porjesz B. Predicting alcohol use disorder remission: a longitudinal multimodal multi-featured machine learning approach. Transl. Psychiatry. 2021;11:166. doi: 10.1038/s41398-021-01281-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kinreich S., Meyers J.L., Maron-Katz A., Kamarajan C., Pandey A.K., Chorlian D.B., Zhang J., Pandey G., Subbie-Saenz de Viteri S., Pitti D., Anokhin A.P., Bauer L., Hesselbrock V., Schuckit M.A., Edenberg H.J., Porjesz B. Predicting risk for alcohol use disorder using longitudinal data with multimodal biomarkers and family history: a machine learning study. Mol. Psychiatr. 2019 doi: 10.1038/s41380-019-0534-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kumari N., Anwar S., Bhattacharjee V. A deep learning-based approach for accurate diagnosis of alcohol usage severity using EEG signals. IETE J. Res. 2023;69:7816–7830. doi: 10.1080/03772063.2022.2038705. [DOI] [Google Scholar]
  24. Lin T., Wang Y., Liu X., Qiu X. A survey of transformers. AI Open. 2022;3:111–132. doi: 10.1016/j.aiopen.2022.10.001. [DOI] [Google Scholar]
  25. Liu E., Luu C., Wu L.C. Resting state EEG variability and implications for interpreting clinical effect sizes. IEEE Trans. Neural Syst. Rehabil. Eng. 2024;32:587–596. doi: 10.1109/tnsre.2024.3355956. [DOI] [PubMed] [Google Scholar]
  26. Luck S.J. second ed. MIT Press; 2014. An Introduction to the Event-Related Potential Technique.https://books.google.com/books?id=SzavAwAAQBAJ [Google Scholar]
  27. Mackey S., Allgaier N., Chaarani B., Spechler P., Orr C., Bunn J., Allen N.B., Alia-Klein N., Batalla A., Blaine S., Brooks S., Caparelli E., Chye Y.Y., Cousijn J., Dagher A., Desrivieres S., Feldstein-Ewing S., Foxe J.J., Goldstein R.Z., et al. Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am. J. Psychiatry. 2019;176:119–128. doi: 10.1176/appi.ajp.2018.17040415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Manivannan G.S., Mani K., Rajaguru H., Talawar S.V. Detection of alcoholic EEG signal using LASSO regression with metaheuristics algorithms based LSTM and enhanced artificial neural network classification algorithms. Sci. Rep. 2024;14 doi: 10.1038/s41598-024-72926-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. McKay D.R., Knowles E.E., Winkler A.A., Sprooten E., Kochunov P., Olvera R.L., Curran J.E., Kent J.W., Jr., Carless M.A., Goring H.H., Dyer T.D., Duggirala R., Almasy L., Fox P.T., Blangero J., Glahn D.C. Influence of age, sex and genetic factors on the human brain. Brain Imag. Behav. 2014;8:143–152. doi: 10.1007/s11682-013-9277-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Meghdadi A.H., Stevanovic Karic M., McConnell M., Rupp G., Richard C., Hamilton J., Salat D., Berka C. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment. PLoS One. 2021;16 doi: 10.1371/journal.pone.0244180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Modesitt E., Yin H., Huang Wang W., Lu B. Lecture Notes in Computer Science. Springer; Nature Switzerland, Cham: 2024. Fusing pretrained ViTs with TCNet for enhanced EEG regression; pp. 47–59.https://link.springer.com/chapter/10.1007/978-3-031-61572-6_4 [Google Scholar]
  32. Mumtaz W., Ali S.S.A., Yasin M.A.M., Malik A.S. A machine learning framework involving EEG-based functional connectivity to diagnose major depressive disorder (MDD) Med. Biol. Eng. Comput. 2018;56:233–246. doi: 10.1007/s11517-017-1685-z. [DOI] [PubMed] [Google Scholar]
  33. Mumtaz W., Vuong P.L., Malik A.S., Rashid R.B.A. A review on EEG-based methods for screening and diagnosing alcohol use disorder. Cogn. Neurodyn. 2018;12:141–156. doi: 10.1007/s11571-017-9465-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Phan H., Mikkelsen K., Chen O.Y., Koch P., Mertins A., De Vos M. SleepTransformer: automatic sleep staging with interpretability and uncertainty quantification. IEEE Trans. Biomed. Eng. 2022;69:2456–2467. doi: 10.1109/TBME.2022.3147187. [DOI] [PubMed] [Google Scholar]
  35. Porjesz B., Rangaswamy M., Kamarajan C., Jones K.A., Padmanabhapillai A., Begleiter H. The utility of neurophysiological markers in the study of alcoholism. Clin. Neurophysiol. 2005;116:993–1018. doi: 10.1016/j.clinph.2004.12.016. [DOI] [PubMed] [Google Scholar]
  36. Prechelt L. In: Neural Networks: Tricks of the Trade. Montavon G., Orr G.B., Müller K.-R., editors. Springer Berlin Heidelberg; Berlin, Heidelberg: 2012. Early stopping — but when? pp. 53–67. [DOI] [Google Scholar]
  37. Pulini A.A., Kerr W.T., Loo S.K., Lenartowicz A. Classification accuracy of neuroimaging biomarkers in attention-Deficit/Hyperactivity disorder: effects of sample size and circular analysis. Biol. Psychiatry Cogn. Neurosci. Neuroimaging. 2019;4:108–120. doi: 10.1016/j.bpsc.2018.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pulver D., Angkan P., Hungler P., Etemad A. Proceedings of the 25th International Conference on Multimodal Interaction, Icmi 2023. 2023. EEG-based cognitive load classification using feature masked autoencoding and emotion transfer learning; pp. 190–197. [DOI] [Google Scholar]
  39. Ranasinghe P.V.N.N., Mapa M.S.T. Functional connectivity and cognitive decline: a review of rs-fMRI, EEG, MEG, and graph theory approaches in aging and dementia. Explorat. Med. 2024;5:797–821. doi: 10.37349/emed.2024.00256. [DOI] [Google Scholar]
  40. Rangaswamy M., Porjesz B., Chorlian D.B., Wang K., Jones K.A., Kuperman S., Rohrbaugh J., O'Connor S.J., Bauer L.O., Reich T., Begleiter H. Resting EEG in offspring of male alcoholics: beta frequencies. Int. J. Psychophysiol. 2004;51:239–251. doi: 10.1016/j.ijpsycho.2003.09.003. [DOI] [PubMed] [Google Scholar]
  41. Roy Y., Banville H., Albuquerque I., Gramfort A., Falk T.H., Faubert J. Deep learning-based electroencephalography analysis: a systematic review. J. Neural. Eng. 2019;16 doi: 10.1088/1741-2552/ab260c. [DOI] [PubMed] [Google Scholar]
  42. Substance Abuse and Mental Health Services Administration . Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. 2025. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2024 Rockville, MD. [Google Scholar]
  43. Sarwar S., Majeed S., Nawaz A., Bibi R., Lee S.W. MDL-CA: a multimodal deep learning approach with a cross attention mechanism for accurate brain cancer diagnosis. Front. Public Health. 2026;13 doi: 10.3389/fpubh.2025.1687335. 2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Scheinost D., Noble S., Horien C., Greene A.S., Lake E.M., Salehi M., Gao S., Shen X., O'Connor D., Barron D.S., Yip S.W., Rosenberg M.D., Constable R.T. Ten simple rules for predictive modeling of individual differences in neuroimaging. Neuroimage. 2019;193:35–45. doi: 10.1016/j.neuroimage.2019.02.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schirrmeister R.T., Springenberg J.T., Fiederer L.D.J., Glasstetter M., Eggensperger K., Tangermann M., Hutter F., Burgard W., Ball T. Deep learning with convolutional neural networks for EEG decoding and visualization. Hum. Brain Mapp. 2017;38:5391–5420. doi: 10.1002/hbm.23730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Shorten C., Khoshgoftaar T.M. A survey on image data augmentation for deep learning. J. Big Data. 2019;6:1–48. doi: 10.1186/s40537-019-0197-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Siddhad G., Gupta A., Dogra D.P., Roy P.P. Efficacy of transformer networks for classification of EEG data. Biomed. Signal Process Control. 2024;87 doi: 10.1016/j.bspc.2023.105488. [DOI] [Google Scholar]
  48. Srinivasan V., Strodthoff N., Ma J., Binder A., Müller K.R., Samek W. To pretrain or not? A systematic analysis of the benefits of pretraining in diabetic retinopathy. PLoS One. 2022;17 doi: 10.1371/journal.pone.0274291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sun Y., Jin W., Si X., Zhang X., Cao J., Wang L., Yin S., Ming D. Continuous seizure detection based on transformer and long-term iEEG. IEEE J. Biomed. Health Inform. 2022;26:5418–5427. doi: 10.1109/JBHI.2022.3199206. [DOI] [PubMed] [Google Scholar]
  50. Tanner D., Morgan-Short K., Luck S.J. How inappropriate high-pass filters can produce artifactual effects and incorrect conclusions in ERP studies of language and cognition. Psychophysiology. 2015;52:997–1009. doi: 10.1111/psyp.12437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Urigüen J.A., Garcia-Zapirain B. EEG artifact removal-state-of-the-art and guidelines. J. Neural. Eng. 2015;12 doi: 10.1088/1741-2560/12/3/031001. [DOI] [PubMed] [Google Scholar]
  52. Vafaei E., Hosseini M. Transformers in EEG analysis: a review of architectures and applications in motor imagery, seizure, and emotion classification. Sensors (Basel) 2025;25 doi: 10.3390/s25051293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Varoquaux G. Cross-validation failure: small sample sizes lead to large error bars. Neuroimage. 2018;180:68–77. doi: 10.1016/j.neuroimage.2017.06.061. [DOI] [PubMed] [Google Scholar]
  54. White A.M., Castle I.P., Powell P.A., Hingson R.W., Koob G.F. Alcohol-Related deaths during the COVID-19 pandemic. JAMA. 2022;327:1704–1706. doi: 10.1001/jama.2022.4308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Widmann A., Schröger E., Maess B. Digital filter design for electrophysiological data - a practical approach. J. Neurosci. Methods. 2015;250:34–46. doi: 10.1016/j.jneumeth.2014.08.002. [DOI] [PubMed] [Google Scholar]
  56. Zahr N.M., Pfefferbaum A. Alcohol's effects on the brain: neuroimaging results in humans and animal models. Alcohol Res. 2017;38:183–206. doi: 10.35946/arcr.v38.2.04. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (29.9KB, docx)

Data Availability Statement

Data will be made available on request.


Articles from Neuroimage: Reports are provided here courtesy of Elsevier

RESOURCES